This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: ABBV BMY CHH OC TROW


AllianceBernstein (AB) was downgraded to hold at TheStreet Ratings.

Abbvie (ABBV - Get Report) was upgraded at BMO Capital to outperform from market perform. $55 price target. Humira can drive impressive growth over the coming quarters, BMO Capital said.

Bristol-Myers (BMY - Get Report) was upgraded at Morgan Stanley to overweight from equal-weight. $60 price target. Estimates also raised, as cancer drugs should drive growth, Morgan Stanley said.

Choice Hotels (CHH - Get Report) was downgraded at Robert Baird to underperform from neutral. Valuation call, based on the premium to its peers, despite a slower growth model, Robert Baird said.

Choice Hotels was upgraded at Credit Suisse to neutral from underperform. $45 price target. Company is positioned well for the current lodging cycle, Credit Suisse said.

[Read: <a target="blank" data-add-tracking="true" href=""><em>A Closer Look at Apple, Google and 5 Really Big Stocks Over $200</em></a>]

Graco (GGG) was downgraded at Oppenheimer to perform from outperform. Company has limited earnings upside potential, Oppenheimer said.

Host Hotels (HST) was downgraded at Wells Fargo to market perform from outperform. Group demand outlook is softening, Wells Fargo said.

Lear was downgraded at Deutsche Bank to hold from buy. Valuation call, based on an $83 price target, Deutsche Bank said.

Owens Corning (OC - Get Report) was downgraded to hold from buy at Keybanc. Consensus earnings expectations appear too high, Keybanc said.

[Read: <a target="blank" data-add-tracking="true" href=""><em>Amazon Rockets, Boeing Flies Higher, But Caterpillar Is Grounded</em></a>]

Owens Corning was downgraded at Bank of America/Merrill Lynch to neutral. Valuation call, based on a $40 price target, Owens Corning said. Estimates were also cut.

Patterson-UTI (PTEN) was upgraded at Goldman Sachs to neutral from sell. $25 price target. Valuation call, as the stock has lagged its peers in recent months, Goldman Sachs said.

Royal Caribbean (RCL) was upgraded to buy at TheStreet Ratings.

Transocean (RIG) was downgraded at Goldman Sachs to sell from neutral. Valuation call, based on a $50 price target, Goldman said.

T. Rowe Price (TROW - Get Report) was upgraded at UBS to buy from neutral. Estimates were also lifted. Outflows from the international portfolio are slowing and company is well-positioned to benefit from increasing industry inflows of active equity products, UBS said. $90 price target.

Stock Comments / EPS Changes

Aon (AON) estimates, price target were increased at Barclays. Driven by upside potential in health exchanges and share buybacks, Barclays said. $82 price target and equal-weight rating.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ABBV $61.00 -0.33%
BMY $72.18 -0.11%
CHH $50.66 -1.57%
OC $46.07 -2.06%
TROW $75.29 -0.63%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs